Dinghang Capital
VC Fund
Dinghang Capital is a VC fund focused on Health Care and Medical. Dinghang Capital provides investors with professional asset management services.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Dinghang Capital invests in
Stages Dinghang Capital invests in
Countries Dinghang Capital invests in
Investment Focus
Industry
- Health Care 3 (50%)
- Medical 2 (33%)
- Pharmaceutical 2 (33%)
- Aerospace 1 (17%)
- Life Science 1 (17%)
Stage
- Seed 2 (33%)
- Funding Round 2 (33%)
- Series B 1 (17%)
- Venture - Series Unknown 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Zhuzhou Hongxing Technology
|
Zhuzhou Hongxing Technology focuses on the engineering application of pulsed plasma thrusters. | Seed / Feb 10, 2026 | |
Shengjisheng Semiconductor
|
Shengjisheng Semiconductor is committed to facilitating the localization of vital semiconductor machinery. It offers technical assistance and replacement parts associated with the production of semiconductors. | Venture - Series Unknown / Dec 07, 2023 | |
META Pharmaceuticals
|
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases. | $15M / Seed / Jun 13, 2022 | |
MGI Tech
|
MGI Tech is committed to enabling effective and affordable healthcare solutions for all. MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare. MGI’s multi-omics platforms include genetic sequencing, mass spectrometry and medical imaging. Providing real-time, comprehensive,life-long solutions, its mission is to advance life science tools and lead digital health innovation. | $1B / Series B / May 28, 2020 | |
iRegene
|
iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases. | Jan 01, 2020 | |
WuXi Biologics
|
WuXi Biologics is a open-access technology platform company offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. Across the global biologics research and development community, we enable our partners to find innovative biological treatments for diseasesworldwide. | Jan 01, 2017 |
Co-Investors
BGI Co-Win
1 deal together
CPE Capital
1 deal together
CITIC Securities
1 deal together
Cornerstone Capital
1 deal together
Cornerstone Capital
1 deal together
Co-Stone Venture Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Dinghang Capital invest in?
Dinghang Capital invests primarily in Health Care, Medical and Pharmaceutical startups, most often at Seed and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dinghang Capital last invest?
The most recent investment recorded for Dinghang Capital closed in Feb 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
